Abstract
During the winter of 2023, Chile faced a complex situation related to the respiratory syncytial virus (RSV). After experiencing a decline in RSV circulation during the years of the SARS-CoV-2 pandemic, a late outbreak was observed in the spring of 2022 and an early onset of the outbreak in 2023, with a significant increase in the number of serious cases. The ineffectiveness of strategic planning and risk communication contributed to the complexity of the situation. To avoid the above next winter, measures such as active surveillance, unification of definitions for acute respiratory infections, identification of RSV variants, public education about infections and advance preparation regarding hospital beds and health personnel are suggested. The importance of immunization and intersectoral collaboration to acquire new preventive alternatives is highlighted, as well as the need for early communication about the importance of immunization and identification of high-risk groups, improvement in training of medical personnel and strategic planning of the Ministry of Health. seeking a proactive and collaborative approach to address the complex RSV situation in future winters. The Chilean Immunization Advisory Committee has already carried out an analysis and recommendation on a new prevention alternative. This working group will support any decision of the Ministry of Health in public policies that attempt a change in the paradigm of control of this disease for the health of the children of our country.
Translated title of the contribution | Strategies and recommendations to face respiratory syncytial virus disease in 2024 |
---|---|
Original language | Spanish |
Pages (from-to) | 17-23 |
Number of pages | 7 |
Journal | Andes Pediatrica |
Volume | 95 |
Issue number | 1 |
DOIs | |
State | Published - 2024 |
Bibliographical note
Publisher Copyright:© 2024, Sociedad Chilena de Pediatria. All rights reserved.
Keywords
- Acute Respiratory Infections
- Immunization
- Late Outbreak
- Ministry of Health
- Risk Communication
- SARSCoV-2 Pandemic
- Syncytial Respiratory Virus (RSV)